Product Name: Tofacitinib Citrate

Definition:
Tofacitinib Citrate is an oral Janus kinase (JAK) inhibitor used in the treatment of autoimmune diseases. It is the citrate salt form of Tofacitinib, a small molecule that selectively targets and inhibits JAK enzymes, which are involved in the signaling of various immune and inflammatory pathways.

Function:
Tofacitinib Citrate works by inhibiting JAK enzymes (JAK1, JAK3, JAK2) to modulate immune system activity. By blocking the signaling pathways that lead to inflammation, it helps reduce symptoms and damage associated with autoimmune disorders.

Applications:

· Pharmaceuticals: Used in the treatment of rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and other inflammatory conditions.

· Medical Treatments: Administered orally as part of long-term management plans for chronic autoimmune diseases.

· Research & Development: Employed in clinical research for new indications and combination therapies in immune-related diseases.